Preventing herpes simplex virus transmission to the neonate

Herpes

Volumn 11, Issue SUPPL. 3, 2004, Pages

  Brown, Zane ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

HSV; Neonatal herpes; Neurological disease; Pregnancy; Serological status; Vertical transmission

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; FAMCICLOVIR; VALACICLOVIR;

CESAREAN SECTION; CLINICAL TRIAL; CONFERENCE PAPER; COST BENEFIT ANALYSIS; DELIVERY; DRUG SAFETY; GENITAL HERPES; HERPES; HERPES SIMPLEX VIRUS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HIGH RISK POPULATION; HUMAN; INFECTION PREVENTION; NEUROLOGICAL COMPLICATION; NEWBORN INFECTION; NEWBORN MORTALITY; PATIENT COUNSELING; PRIORITY JOURNAL; RECURRENT INFECTION; SERODIAGNOSIS; SEXUAL BEHAVIOR; VERTICAL TRANSMISSION; VIRUS CULTURE; VIRUS SHEDDING; VIRUS TRANSMISSION;

ANTIVIRAL AGENTS; CESAREAN SECTION; DISEASE TRANSMISSION, VERTICAL; FEMALE; HERPES SIMPLEX; HUMANS; INFANT, NEWBORN; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

HERPES; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; SIMPLEXVIRUS;

EID: 4344647944     PISSN: 09697667     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (68)

1. Forsgren M, Herpes simplex virus infection in the perinatal period. Rev Med Microbiol 1992;3:129-136.
2. Whitley R. Neonatal herpes simplex virus infections. J Med Virol 1993;71:58-66.
3. Brown ZA, Wald A, Ashley R, Selke S, Zeh J, Corey L. Effect of serologic status and abdominal deliveries on transmission rates of HSV from mother to infant. JAMA 2003;289:203-209.
4. Tookey P, Peckham CS. Neonatal herpes simplex virus infection in the British Isles. Paediatr Perinat Epidemiol 1996;10:432-442.
5. Garland SM. Neonatal herpes simplex: Royal Women's Hospital 10-year experience with management guidelines for herpes in pregnancy. Aust N Z J Obstet Gynaecol 1992; 32:331-334.
6. Whitley RJ. Neonatal herpes simplex virus infections. Clin Perinatol 1988;15:903-916.
7. Corey L, Whitley RJ, Stone EF, Mohan K. Difference between herpes simplex virus type 1 and type 2 neonatal encephalitis in neurological outcome. Lancet 1988;i:1-4.
8. Pass R, Weber T, Whitley RJ. Herpesvirus Infections in Pregnancy. Worthing: PAREXEL MMS Europe Ltd, 2000;12-21.
9. Whitley R, Arvin A, Prober C, Burchett S, Corey L, Powell D et al. A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection. Infectious Diseases Collaborative Antiviral Study Group. N Engl J Med 1991;324:444-449.
10. Elder DE, Minutillo C, Pemberton PJ. Neonatal herpes simplex infection: keys to early diagnosis. J Paediatr Child Health 1995;31:307-311.
11. Vontver LA, Hickok DE, Brown Z, Reid L, Corey L. Recurrent genital herpes simplex virus infection in pregnancy: infant outcome and frequency of asymptomatic recurrences. Am J Obstet Gynecol 1982;143:75-84.
12. Harger JH, Pazin GJ, Armstrong JA, Breinig MC, Ho M. Characteristics and management of pregnancy in women with genital herpes simplex virus infection. Am J Obstet Gynecol 1983;145: 784-791.
13. Parvey LS, Ch'ien LT. Neonatal herpes simplex virus infection introduced by fetal-monitor scalp electrodes. Pediatrics 1980;65:1150-1153.
14. Kaye EM, Dooling EC. Neonatal herpes simplex meningoencephalitis associated with fetal monitor scalp electrodes. Neurology 1981;31:1045-1047.
15. Kohelet D, Katz N, Sadan O, Somekh E. Herpes simplex virus infection after vacuum-assisted vaginally delivered infants of asymptomatic mothers. J Perinatol 2004;24:147-149.
16. Libman MD, Dascal A, Kramer MS, Mendelson J. Strategies for the prevention of neonatal infection with herpes simplex virus: a decision analysis. Rev Infect Dis 1991;13:1093-1104.
17. Hutto C, Arvin A, Jacobs R, Steele R, Stagno S, Lyrene R et al. Intrauterine herpes simplex virus infections. J Pediatr 1987;110:97-101.
18. Mercey D, Mindel A. Screening pregnant women for genital herpes. Biomed Pharmacother 1990;44: 257-262.
19. Brown ZA, Benedetti J, Ashley R, Burchett S, Selke S, Berry S et al. Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor. N Engl J Med 1991; 324:1247-1252.
20. Brown ZA, Selke S, Zeh J, Kopelman J, Maslow A, Ashley RL et al. The acquisition of herpes simplex virus during pregnancy. N Engl J Med 1997;337: 509-515.
21. Prober CG, Sullender WM, Yasukawa LL, Au DS, Yeager AS, Arvin AM. Low risk of herpes simplex virus infections in neonates exposed to the virus at the time of vaginal delivery to mothers with recurrent genital herpes simplex virus infections. N Engl J Med 1987;316:240-244.
22. Brown ZA. HSV-2 specific serology should be offered routinely to antenatal patients. Rev Med Virol 2000;10:141-144.
23. Watts DH, Brown ZA, Money D, Selke S, Huang ML, Sacks S et al. A double-blind, randomized, placebo-controlled trial of acyclovir in late pregnancy for the reduction of herpes simplex virus shedding and cesarean delivery. Am J Obstet Gynecol 2003;188:836-843.
24. Stagno S, Whitley R. Herpes Virus Infections in the Neonate and Children. 2nd edn. New York: McGraw Hill, 1990.
25. Corey L, Wald A. Genital herpes. In: Sexually-Transmitted Diseases (Holmes KK, Sparling PF, Mardh PA, eds). New York: McGraw Hill Publishers, 1998:pp285-312.
26. Stagno S, Whitley RJ. Herpesvirus infections of pregnancy. Part II: Herpes simplex virus and varicella-zoster virus infections. N Engl J Med 1985;313:1327-1330.
27. Gibson JJ, Hornung CA, Alexander GR, Lee FK, Potts WA, Nahmias AJ. A cross-sectional study of herpes simplex virus types 1 and 2 in college students: occurrence and determinants of infection. J Infect Dis 1990; 162:306-312.
28. Mertz GJ, Benedetti J, Ashley R, Selke SA, Corey L. Risk factors for the sexual transmission of genital herpes. Ann Intern Med 1992;116:197-202.
29. Bryson Y, Dillon M, Bernstein DI, Radolf J, Zakowski P, Garratty E. Risk of acquisition of genital herpes simplex virus type 2 in sex partners of persons with genital herpes: a prospective couple study. J Infect Dis 1993;167:942-946.
30. Fonnest G, de la Fuente Fonnest I, Weber T. Neonatal herpes in Denmark 1977-1991. Acta Obstet Gynecol Scand 1997;76:355-358.
31. Brown ZA, Benedetti J, Selke S, Ashley R, Watts DH, Corey L. Asymptomatic maternal shedding of herpes simplex virus at the onset of labor: relationship to preterm labor. Obstet Gynecol 1996;87: 483-488.
32. Yeager AS, Arvin AM, Urbani LJ, Kemp JA, 3rd. Relationship of antibody to outcome in neonatal herpes simplex virus infections. Infect Immun 1980;29: 532-538.
33. Prober CG, Corey L, Brown ZA, Hensleigh PA, Frenkel LM, Bryson YJ et al. The management of pregnancies complicated by genital infections with herpes simplex virus. Clin Infect Dis 1992;15:1031-1038.
34. Nahmias AJ, Josey WE, Naib ZM, Freeman MG, Fernandez RJ, Wheeler JH. Perinatal risk associated with maternal genital herpes simplex virus infection. Am J Obstet Gynecol 1971;110:825-837.
35. Mertz GJ. Epidemiology of genital herpes infections. Infect Dis Clin North Am 1993;7:825-839.
36. Arvin AM, Hensleigh PA, Prober CG, Au DS, Yasukawa LL, Wittek AE et al. Failure of antepartum maternal cultures to predict the infant's risk of exposure to herpes simplex virus at delivery. N Engl J Med 1986;315:796-800.
37. Griffiths PD, Volpi A. Progress with Diagnostic Tests and Vaccines for Alpha-herpesviruses. Worthing: PAREXEL MMS Europe Ltd, 1998.
38. Hensleigh PA, Andrews WW, Brown Z, Greenspoon J, Yasukawa L, Prober CG. Genital herpes during pregnancy: inability to distinguish primary and recurrent infections clinically. Obstet Gynecol 1997;89:891-895.
39. Brown ZA, Benedetti JK, Watts DH, Selke S, Berry S, Ashley RL et al. A comparison between detailed and simple histories in the diagnosis of genital herpes complicating pregnancy. Am J Obstet Gynecol 1995;172: 1299-1303.
40. Corey L, Adams HG, Brown ZA, Holmes KK. Genital herpes simplex virus infections: clinical manifestations, course, and complications. Ann Intern Med 1983;98:958-972.
41. Koutsky LA, Ashley RL, Holmes KK, Stevens CE, Critchlow CW, Kiviat N et al. The frequency of unrecognized type 2 herpes simplex virus infection among women. Implications for the control of genital herpes. Sex Transm Dis 1990;17:90-94.
42. Grossman JH, 3rd, Wallen WC, Sever JL. Management of genital herpes simplex virus infection during pregnancy. Obstet Gynecol 1981;58:1-4.
43. Boehm FH, Estes W, Wright PF, Growdon JF, Jr. Management of genital herpes simplex virus infection occurring during pregnancy. Am J Obstet Gynecol 1981; 141:735-740.
44. Stone KM, Brooks CA, Guinan ME, Alexander ER. National surveillance for neonatal herpes simplex virus infections. Sex Transm Dis 1989;16:152-156.
45. Koskiniemi M, Happonen JM, Jarvenpaa AL, Pettay O, Vaheri A. Neonatal herpes simplex virus infection: a report of 43 patients. Pediatr Infect Dis J 1989;8:30-35.
46. van Everdingen JJ, Peeters MF, ten Have P. Neonatal herpes policy in The Netherlands. Five years after a consensus conference. J Perinat Med 1993;21: 371-375.
47. Gutierrez KM, Falkovitz Halpern MS, Maldonado Y, Arvin AM. The epidemiology of neonatal herpes simplex virus infections in California from 1985 to 1995. J Infect Dis 1999;180:199-202.
48. Roberts SW, Cox SM, Dax J, Wendel GD, Jr, Leveno KJ. Genital herpes during pregnancy: no lesions, no cesarean. Obstet Gynecol 1995;85:261-264.
49. Randolph AG, Washington AE, Prober CG. Cesarean delivery for women presenting with genital herpes lesions. Efficacy, risks, and costs. JAMA 1993;270: 77-82.
50. Reiff-Eldridge R, Heffner CR, Ephross SA, Tennis PS, White AD, Andrews EB. Monitoring pregnancy outcomes after prenatal drug exposure through prospective pregnancy registries: a pharmaceutical company commitment. Am J Obstet Gynecol 2000;182:159-163.
51. Sexually transmitted diseases treatment guidelines 2002. Centers for Disease Control and Prevention. MMWR Recomm Rep 2002;51:1-78.
52. Frenkel LM, Brown ZA, Bryson YJ, Corey L, Unadkat JD, Hensleigh PA et al. Pharmacokinetics of acyclovir in the term human pregnancy and neonate. Am J Obstet Gynecol 1991;164: 569-576.
53. Meyer LJ, de Miranda P, Sheth N, Spruance S. Acyclovir in human breast milk. Am J Obstet Gynecol 1988;158:586-588.
54. Sheffield JS, Hollier LM, Hill JB, Stuart GS, Wendel GD. Acyclovir prophylaxis to prevent herpes simplex virus recurrence at delivery: a systematic review. Obstet Gynecol 2003;102: 1396-1403.
55. Stray-Pedersen B. Acyclovir in late pregnancy to prevent neonatal herpes simplex. Lancet 1990;336:756.
56. Scott LL, Sanchez PJ, Jackson GL, Zeray F, Wendel GD, Jr. Acyclovir suppression to prevent cesarean delivery after first-episode genital herpes. Obstet Gynecol 1996;87:69-73.
57. Brocklehurst P, Kinghorn G, Carney O, Helsen K, Ross E, Ellis E et al. A randomised placebo controlled trial of suppressive acyclovir in late pregnancy in women with recurrent genital herpes infection. Br J Obstet Gynoecol 1998;105:275-280.
58. Braig S, Luton D, Sibony O, Edlinger C, Boissinot C, Blot P et al. Acyclovir prophylaxis in late pregnancy prevents recurrent genital herpes and viral shedding. Eur J Obstet GynecoI Reprod Biol 2001; 96:55-58.
59. Scott LL, Hollier LM, McIntire D, Sanchez PJ, Jackson GL, Wendel GD, Jr. Acyclovir suppression to prevent clinical recurrences at delivery after first episode genital herpes in pregnancy: an open-label trial. Infect Dis Obstet Gynecol 2001;9:75-80.
60. Scott LL. Prevention of perinatal herpes: prophylactic antiviral therapy? Clin Obstet Gynecol 1999;42:134-148.
61. Scott LL, Alexander J. Cost-effectiveness of acyclovir suppression to prevent recurrent genital herpes in term pregnancy. Am J Perinotol 1998;15:57-62.
62. Kimberlin DF, Weller S, Whitley RJ, Andrews WW, Hauth JC, Lakeman F et al. Pharmacokinetics of oral valacyclovir and acyclovir in late pregnancy. Am J Obstet Gynecol 1998;179:846-851.
63. Beutner KR. Valacyclovir: a review of its antiviral activity, pharmacokinetic properties, and clinical efficacy. Antiviral Res 1995;28:281-290.
64. Acosta EP, Fletcher CV. Valacyclovir. Ann Pharmacother 1997;31: 185-191.
65. von Sydow K. Sexuality during pregnancy and after childbirth: a metacontent analysis of 59 studies. J Psychosom Res 1999;47: 27-49.
66. Kulhanjian JA, Soroush V, Au DS, Bronzan RN, Yasukawa LL, Weylman LE et al. Identification of women at unsuspected risk of primary infection with herpes simplex virus type 2 during pregnancy. N Engl J Med 1992;326:916-920.
67. Corey L, Wald A, Patel R, Sacks SL, Tyring SR, Warren T et al. Once daily valaciclovir to reduce the transmission of genital herpes. N Engl J Med 2004;350:11-20.
68. Baker D, Brown Z, Hollier L, Wendel G, Hulme L, Griffiths D et al. Cost-effectiveness of herpes simplex virus type 2 serological testing and antiviral therapy in pregnancy. Am J Ob Gyn 2004 (in press).